Neuroprotection in Aβ25-35 -Induced Alzheimer's Disease Model by Hawthorn Leaf Flavonoids

Clicks: 139
ID: 276375
2022
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #8 of 13 articles by views in Phytopharmacological Communications

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
It has been observed that increased accumulation of Aβ peptides in the brain triggers endogenous oxidative stress, neuroinflammation, and memory dysfunction in Alzheimer’s Disease (AD). Crataegus pinnatifida Bge. Commonly referred to as the Hawthorn leaf is a well-known traditional Chinese medicine. The plant is used for conditions such as hyperlipidemia, heart palpitations, forgetfulness, and tinnitus in mainstream medicinal practice, where the most important bioactive components consist of Hawthorn Leaf Flavonoids (HLF). Xu and associates showed that in a rat model given Aβ25-35 (bilateral hippocampus injection), the neuroprotective effects of HLF were significant. Oral doses of 50, 100, and 200 mg/kg for a time period of 30 days of HLF demonstrated significant attenuation of the damage to neurons alongside marked inhibition in memory deficits. Enhancement in the enzyme activities of superoxide dismutase and catalase, and glutathione content was seen. In contrast, HLF decreased the malondialdehyde content in the Aβ25-35 rat AD model and suppressed astrocytes’ activation, ameliorating neuroinflammation. HLF upregulated NQO-1, Nrf-2, and HO-1 protein expressions. These results demonstrated the potential of HLF as a potential AD therapeutic. Phytother Res (2022) DOI: 10.1002/ptr.7690.   
Reference Key
Staff2022phytopharmacologicalNeuroprotection Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Editorial Staff;
Journal Phytopharmacological Communications
Year 2022
DOI
166
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.